SlideShare a Scribd company logo
Introduction to QSAR ,[object Object]
Risk assessments are based on test data, and QSAR is not needed if you have lot’s of data
However, if data gaps exist, one can defer the hazard assessment or use QSAR  ,[object Object]
The world inventory of produced chemicals exceeds 160,000 chemicals
 The world capacity for SIDS initial hazard assessments is only ~500 chemicals/year,[object Object]
Also, priority setting for 130,000 chemicals will require faster testing or better models
In QSAR, estimating behavior of untested chemicals has been used for >60 years  ,[object Object]
Like most systems, the behavior of a chemical is derived from its structure
Chemical behavior in biological systems is described as biological activity of chemicals  ,[object Object]
QSAR is the acronym for Quantitative Structure-Activity Relationship
log LC50 (rat, 4hr) = 0.69 log VP + 1.54 is an example of QSAR for lethality in rats,[object Object]
There are more than 15,000 published QSARs for biological activity endpoints
The term “quantitative” most often pertains to the statistical quality of the “relationship”,[object Object]
Only chemicals causing common toxicity mechanisms lead to a reliable QSAR
Therefore, QSAR must group chemical behavior in terms of toxicity mechanisms ,[object Object]
Each QSAR predicts a specific endpoint and only for chemicals with the same mechanism
Errors of choosing the wrong QSAR (mechanism) are larger than model errors,[object Object]
Example for Lethality in Mice ,[object Object]
Data restricted to alkyl ethers to increase likelihood of a similar toxicity mechanism
Estimate or measure vapor pressure as molecular descriptor (selected from theory or by trial-n-error)
Correlate LC50 with VP to get:      log LC50 = 0.57 x log VP + 2.08
Example ,[object Object]
Notice the intercept is about 0.5 log units greater for 30 min mouse vs 4 hr rat LC50
Can you suggest reasons for the greater LC50 (lower toxicity) for 30 min mouse ?,[object Object]
This QSAR implies vapor pressure is important  to the lethality mechanism for these chemicals
Chemicals with other mechanisms  (i.e. acrolein, phosgene) will appear as statistical outliers
QSAR provides insights into chemical similarity in terms of common  “effect” mechanisms,[object Object]
QSAR is also a tool to group chemicals which can be expected to behave similarity (same toxicity pathway under specific test conditions,[object Object]
Entire categories of chemicals can be assessed when only a few are tested
Filling missing data (gaps) involves read-across & trend or correlation analysis ,[object Object]
Annex IX of REACH  Substances whose physicochemical, toxicological and ecotoxicological properties are likely to besimilar or follow a regular patternas a result of structural similarity may be considered as a group, or “category” of substances.  Application of the group concept requires that physicochemical properties, human health effects and environmental effects or environmental fate may bepredicted from data for a reference substancewithin the group by interpolation to other substances in the group (read-across approach). Thisavoids the need to test every substance for every endpoint.
OECD Definition of Category ,[object Object]
These structural similarities may create a predictable pattern in any or all of the following parameters: physicochemical properties, environmental fate and environmental effects, and human health effectsOECD Manual for Investigation of High Production Volume (HPV) Chemicals.
Forming Chemical Categories Chemical categories have boundary conditions which vary with endpoints Without  detailed understanding of metabolism or mechanisms, grouping similarity of behavior is difficult to define. Ironically, examining data trends with different category boundaries is a flexible way to define categories
Canonical Ordering Chemical Amyl amine Amyl chloride Dibromobenzene Ethyl bromide n-Heptanol Methacrolein Methyl-p-anisylketone n-Octane n-Nonane Boiling Point °C 103-4 98-9 219-2 38.4 192 68 267-9 126 151
Canonical Ordering Chemical Ethyl bromide Methacrolein Amyl chloride Amyl amine n-Octane n-Nonane n-Heptanol Dibromobenzene Methyl-p-anisylketone Boiling Point °C 38.4 68 98-9 103-4 126 151 192 219-2 267-9
Modeling Chemical Potency 10+2 10 0 10_2 1/LC50 (Moles/L) It is not uncommon  to  find endpoint values spanning 6-10 orders  for a  single  toxicity mechanism  10_4 10_6 10-8 1 2 3 4 5 N < 10,000 ….... TOXICITY “MECHANISMS”
Modeling Chemical Potency 10+2 10 0 10_2 1/LC50 (Chemical Activity) 10_4 10_6 10-8 0 2 4 6 8 LOG K o/w
QSAR Methods QSAR fills data gaps by first grouping chemicals and then using existing data within a group to estimate missing values When the chemical group is identified by a common mechanism, QSAR models can accurately describe the trends
Why Do We Need the QSAR Toolbox Defining category boundaries requires the calculation of complex attributes of chemicals to determine which best explains available data In many cases, metabolic simulators are needed to provide metabolic maps and active metabolites  To do trend analysis, hundreds of available data must be compiled and flexibly analyzed for trends
Which Metabolite should we use in modeling interactions? Simulated  2-Acetylaminofluorene  Metabolism
Adverse Outcome Pathway For A Well-Defined Endpoint Molecular Initiating  Event Speciation, Metabolism Reactivity Etc. In Vitro  and  System  Effects In Vivo Adverse  Outcomes Parent Chemical Up-Stream                           Down-Stream CHEMISTRYBIOLOGY        Structure-Activity           Levels of Organization
MolecularInitiating Event Macro -Molecular Interactions Toxicant Chemical Reactivity Profiles Receptor, DNA, Protein Interactions Biological Responses Mechanistic Profiling The Adverse Outcome Pathway
MolecularInitiating Event Biological Responses Macro -Molecular Interactions Toxicant Cellular Gene Activation Protein Production Signal Alteration Chemical Reactivity Profiles Receptor, DNA, Protein Interactions NRC Toxicological Pathway The Adverse Outcome Pathway
MolecularInitiating Event Biological Responses Macro -Molecular Interactions Tissue/ Organ Toxicant Cellular Gene Activation Protein Production Signal Alteration Receptor, DNA, Protein Interactions Altered Function  Altered Development Chemical Reactivity Profiles Mechanistic Profiling In Vitro & HTP Screening The Adverse Outcome Pathway
MolecularInitiating Event Biological Responses Macro -Molecular Interactions Toxicant Cellular Organism Organ Population Lethality Sensitization Birth Defect Reproductive Impairment Cancer Gene Activation Protein Production Signal Alteration Altered Function  Altered Development Chemical Reactivity Profiles Receptor, DNA, Protein Interactions Structure Extinction Mechanistic Profiling In Vivo Testing In Vitro & HTP Screening The Adverse Outcome Pathway
Major Pathways for Reactive Toxicity from Moderate Electrophiles Interaction Mechanisms Molecular Initiating Events In vivo Endpoints Exposed Surface Irritation Michael Addition Schiff base Formation SN2 Acylation Atom Centered  Irreversible (Covalent) Binding  Necrosis Which Tissues? Pr-S Adducts GSH Oxidation GSH Depletion NH2 Adducts RN Adducts DNA  Adducts Oxidative  Stress Systemic  Responses Skin Liver Lung Systemic Immune Responses Dose-Dependent Effects

More Related Content

What's hot

Qsar studies
Qsar studiesQsar studies
Qsar studies
routhusree
 
Free wilson analysis qsar
Free wilson analysis qsarFree wilson analysis qsar
Free wilson analysis qsar
Rahul B S
 
Qsar and drug design ppt
Qsar and drug design pptQsar and drug design ppt
Qsar and drug design ppt
Abhik Seal
 
Ashish(qsar)
Ashish(qsar)Ashish(qsar)
Ashish(qsar)
Chandrika Mourya
 
Virtual Screening in Drug Discovery
Virtual Screening in Drug DiscoveryVirtual Screening in Drug Discovery
Virtual Screening in Drug Discovery
Abhik Seal
 
Free wilson analysis
Free wilson analysisFree wilson analysis
Free wilson analysis
ASHOK GAUTAM
 
Insilico methods for design of novel inhibitors of Human leukocyte elastase
Insilico methods for design of novel inhibitors of Human leukocyte elastaseInsilico methods for design of novel inhibitors of Human leukocyte elastase
Insilico methods for design of novel inhibitors of Human leukocyte elastase
Jayashankar Lakshmanan
 
Relationship between hansch analysis and free wilson analysis
Relationship between hansch analysis and free wilson analysisRelationship between hansch analysis and free wilson analysis
Relationship between hansch analysis and free wilson analysis
KomalJAIN122
 
3 D QSAR Approaches and Contour Map Analysis
3 D QSAR Approaches and Contour Map Analysis3 D QSAR Approaches and Contour Map Analysis
3 D QSAR Approaches and Contour Map Analysis
Baddi University of Emerging sciences and Technology
 
QSAR quantitative structure activity relationship
QSAR quantitative structure activity relationship QSAR quantitative structure activity relationship
QSAR quantitative structure activity relationship
ZarlishAttique1
 
Quantitative Structure Activity Relationship.pptx
Quantitative Structure Activity Relationship.pptxQuantitative Structure Activity Relationship.pptx
Quantitative Structure Activity Relationship.pptx
RadhaChafle1
 
De novo drug design
De novo drug designDe novo drug design
De novo drug design
Prasanthperceptron
 
Pharmacophore mapping in Drug Development
Pharmacophore mapping in Drug DevelopmentPharmacophore mapping in Drug Development
Pharmacophore mapping in Drug Development
Mbachu Chinedu
 
2D QSAR DESCRIPTORS
2D QSAR DESCRIPTORS2D QSAR DESCRIPTORS
2D QSAR DESCRIPTORS
Smita Jain
 
Basics of QSAR Modeling
Basics of QSAR ModelingBasics of QSAR Modeling
Basics of QSAR Modeling
Prachi Pradeep
 
Quantitative Structure Activity Relationship
Quantitative Structure Activity RelationshipQuantitative Structure Activity Relationship
Quantitative Structure Activity Relationship
RaniBhagat1
 
Computational Drug Design
Computational Drug DesignComputational Drug Design
Computational Drug Design
baoilleach
 
Molecular docking
Molecular dockingMolecular docking
Quantative Structure-Activity Relationships (QSAR)
Quantative Structure-Activity Relationships (QSAR)Quantative Structure-Activity Relationships (QSAR)
Quantative Structure-Activity Relationships (QSAR)Atai Rabby
 

What's hot (20)

Qsar studies
Qsar studiesQsar studies
Qsar studies
 
Free wilson analysis qsar
Free wilson analysis qsarFree wilson analysis qsar
Free wilson analysis qsar
 
Qsar and drug design ppt
Qsar and drug design pptQsar and drug design ppt
Qsar and drug design ppt
 
Ashish(qsar)
Ashish(qsar)Ashish(qsar)
Ashish(qsar)
 
Virtual Screening in Drug Discovery
Virtual Screening in Drug DiscoveryVirtual Screening in Drug Discovery
Virtual Screening in Drug Discovery
 
Free wilson analysis
Free wilson analysisFree wilson analysis
Free wilson analysis
 
Insilico methods for design of novel inhibitors of Human leukocyte elastase
Insilico methods for design of novel inhibitors of Human leukocyte elastaseInsilico methods for design of novel inhibitors of Human leukocyte elastase
Insilico methods for design of novel inhibitors of Human leukocyte elastase
 
Relationship between hansch analysis and free wilson analysis
Relationship between hansch analysis and free wilson analysisRelationship between hansch analysis and free wilson analysis
Relationship between hansch analysis and free wilson analysis
 
3 D QSAR Approaches and Contour Map Analysis
3 D QSAR Approaches and Contour Map Analysis3 D QSAR Approaches and Contour Map Analysis
3 D QSAR Approaches and Contour Map Analysis
 
QSAR quantitative structure activity relationship
QSAR quantitative structure activity relationship QSAR quantitative structure activity relationship
QSAR quantitative structure activity relationship
 
Quantitative Structure Activity Relationship.pptx
Quantitative Structure Activity Relationship.pptxQuantitative Structure Activity Relationship.pptx
Quantitative Structure Activity Relationship.pptx
 
De novo drug design
De novo drug designDe novo drug design
De novo drug design
 
Lecture 5
Lecture 5Lecture 5
Lecture 5
 
Pharmacophore mapping in Drug Development
Pharmacophore mapping in Drug DevelopmentPharmacophore mapping in Drug Development
Pharmacophore mapping in Drug Development
 
2D QSAR DESCRIPTORS
2D QSAR DESCRIPTORS2D QSAR DESCRIPTORS
2D QSAR DESCRIPTORS
 
Basics of QSAR Modeling
Basics of QSAR ModelingBasics of QSAR Modeling
Basics of QSAR Modeling
 
Quantitative Structure Activity Relationship
Quantitative Structure Activity RelationshipQuantitative Structure Activity Relationship
Quantitative Structure Activity Relationship
 
Computational Drug Design
Computational Drug DesignComputational Drug Design
Computational Drug Design
 
Molecular docking
Molecular dockingMolecular docking
Molecular docking
 
Quantative Structure-Activity Relationships (QSAR)
Quantative Structure-Activity Relationships (QSAR)Quantative Structure-Activity Relationships (QSAR)
Quantative Structure-Activity Relationships (QSAR)
 

Viewers also liked

Qsar
QsarQsar
Qsar
nehla313
 
QSAR
QSARQSAR
Qsar by hansch analysis
Qsar by hansch analysisQsar by hansch analysis
Qsar by hansch analysis
bhavnesh munjal
 
General Concepts in QSAR for Using the QSAR Application Toolbox Part 3
General Concepts in QSAR for Using the QSAR Application Toolbox Part 3General Concepts in QSAR for Using the QSAR Application Toolbox Part 3
General Concepts in QSAR for Using the QSAR Application Toolbox Part 3International QSAR Foundation
 
General Concepts in QSAR for Using the QSAR Application Toolbox Part 1
General Concepts in QSAR for Using the QSAR Application Toolbox Part 1General Concepts in QSAR for Using the QSAR Application Toolbox Part 1
General Concepts in QSAR for Using the QSAR Application Toolbox Part 1
International QSAR Foundation
 
Automating Drug Design Nov 13th 2009 97
Automating Drug Design Nov 13th 2009 97Automating Drug Design Nov 13th 2009 97
Automating Drug Design Nov 13th 2009 97David Leahy
 
Molecular design of life
Molecular design of lifeMolecular design of life
Molecular design of life
Tan Fransisca Dian
 
Molecular design
Molecular designMolecular design
Discovery Bus: UK QSAR meeting at GSK
Discovery Bus: UK QSAR meeting at GSKDiscovery Bus: UK QSAR meeting at GSK
Discovery Bus: UK QSAR meeting at GSK
David Leahy
 
Qsar introduction beginners
Qsar introduction beginnersQsar introduction beginners
Qsar introduction beginnersAntonio Cassano
 
QSAR Study on Antitubercular Drug Derivatives
QSAR Study on Antitubercular Drug DerivativesQSAR Study on Antitubercular Drug Derivatives
QSAR Study on Antitubercular Drug DerivativesLydia Yeshitla
 
Qsar studies of saponine analogues for anticancer activity by sagar alone
Qsar studies of saponine analogues for anticancer activity by sagar aloneQsar studies of saponine analogues for anticancer activity by sagar alone
Qsar studies of saponine analogues for anticancer activity by sagar alonesagar alone
 
Data Analysis in QSAR
Data Analysis in QSARData Analysis in QSAR
Data Analysis in QSAR
baoilleach
 
Effect of substituents and functions on drug structure activity relationships
Effect of substituents and functions on drug structure activity relationshipsEffect of substituents and functions on drug structure activity relationships
Effect of substituents and functions on drug structure activity relationships
Omar Sokkar
 
Computer aided drug design
Computer aided drug designComputer aided drug design
Computer aided drug design
Ali Ahsan
 
Introduction to Quantitative Structure Activity Relationships
Introduction to Quantitative Structure Activity RelationshipsIntroduction to Quantitative Structure Activity Relationships
Introduction to Quantitative Structure Activity Relationships
Omar Sokkar
 
Meta QSAR
Meta QSARMeta QSAR
Meta QSAR
David Leahy
 

Viewers also liked (20)

Qsar
QsarQsar
Qsar
 
QSAR
QSARQSAR
QSAR
 
Qsar by hansch analysis
Qsar by hansch analysisQsar by hansch analysis
Qsar by hansch analysis
 
Qsar
QsarQsar
Qsar
 
General Concepts in QSAR for Using the QSAR Application Toolbox Part 3
General Concepts in QSAR for Using the QSAR Application Toolbox Part 3General Concepts in QSAR for Using the QSAR Application Toolbox Part 3
General Concepts in QSAR for Using the QSAR Application Toolbox Part 3
 
General Concepts in QSAR for Using the QSAR Application Toolbox Part 1
General Concepts in QSAR for Using the QSAR Application Toolbox Part 1General Concepts in QSAR for Using the QSAR Application Toolbox Part 1
General Concepts in QSAR for Using the QSAR Application Toolbox Part 1
 
Automating Drug Design Nov 13th 2009 97
Automating Drug Design Nov 13th 2009 97Automating Drug Design Nov 13th 2009 97
Automating Drug Design Nov 13th 2009 97
 
Molecular design of life
Molecular design of lifeMolecular design of life
Molecular design of life
 
Molecular design
Molecular designMolecular design
Molecular design
 
Discovery Bus: UK QSAR meeting at GSK
Discovery Bus: UK QSAR meeting at GSKDiscovery Bus: UK QSAR meeting at GSK
Discovery Bus: UK QSAR meeting at GSK
 
Qsar introduction beginners
Qsar introduction beginnersQsar introduction beginners
Qsar introduction beginners
 
QSAR Study on Antitubercular Drug Derivatives
QSAR Study on Antitubercular Drug DerivativesQSAR Study on Antitubercular Drug Derivatives
QSAR Study on Antitubercular Drug Derivatives
 
Qsar studies of saponine analogues for anticancer activity by sagar alone
Qsar studies of saponine analogues for anticancer activity by sagar aloneQsar studies of saponine analogues for anticancer activity by sagar alone
Qsar studies of saponine analogues for anticancer activity by sagar alone
 
Data Analysis in QSAR
Data Analysis in QSARData Analysis in QSAR
Data Analysis in QSAR
 
25.qsar
25.qsar25.qsar
25.qsar
 
Effect of substituents and functions on drug structure activity relationships
Effect of substituents and functions on drug structure activity relationshipsEffect of substituents and functions on drug structure activity relationships
Effect of substituents and functions on drug structure activity relationships
 
Computer aided drug design
Computer aided drug designComputer aided drug design
Computer aided drug design
 
Introduction to Quantitative Structure Activity Relationships
Introduction to Quantitative Structure Activity RelationshipsIntroduction to Quantitative Structure Activity Relationships
Introduction to Quantitative Structure Activity Relationships
 
Meta QSAR
Meta QSARMeta QSAR
Meta QSAR
 
Computer Aided Drug Design
Computer Aided Drug DesignComputer Aided Drug Design
Computer Aided Drug Design
 

Similar to Introduction to OECD QSAR Toolbox

qsar.pptx
qsar.pptxqsar.pptx
qsar.pptx
RohithK65
 
Raypur(NEW) QSAR.pptx
Raypur(NEW) QSAR.pptxRaypur(NEW) QSAR.pptx
Raypur(NEW) QSAR.pptx
DrRajeshDas
 
Raypur(NEW) QSAR.pptx
Raypur(NEW) QSAR.pptxRaypur(NEW) QSAR.pptx
Raypur(NEW) QSAR.pptx
DrRajeshDas
 
General Concepts in QSAR for Using the QSAR Application Toolbox Part 2
General Concepts in QSAR for Using the QSAR Application Toolbox Part 2General Concepts in QSAR for Using the QSAR Application Toolbox Part 2
General Concepts in QSAR for Using the QSAR Application Toolbox Part 2
International QSAR Foundation
 
Computer-aided prediction of xenobiotics toxicity
Computer-aided prediction of xenobiotics toxicityComputer-aided prediction of xenobiotics toxicity
Computer-aided prediction of xenobiotics toxicity
Mobiliuz
 
Exploiting enhanced non-testing approaches to meet the needs for sustainable ...
Exploiting enhanced non-testing approaches to meet the needs for sustainable ...Exploiting enhanced non-testing approaches to meet the needs for sustainable ...
Exploiting enhanced non-testing approaches to meet the needs for sustainable ...
US Environmental Protection Agency (EPA), Center for Computational Toxicology and Exposure
 
QSPR For Pharmacokinetics
QSPR For PharmacokineticsQSPR For Pharmacokinetics
QSPR For Pharmacokinetics
shatavaribhosale
 
Qsar ppt
Qsar pptQsar ppt
E0362430
E0362430E0362430
E0362430
IOSR Journals
 
cadd-191129134050 (1).pptx
cadd-191129134050 (1).pptxcadd-191129134050 (1).pptx
cadd-191129134050 (1).pptx
Noorelhuda2
 
Drug development approaches
Drug development approaches Drug development approaches
Drug development approaches
VIOLINA KALITA
 
CADD
CADDCADD
Methods and Approaches for Defining Mechanism Signatures from Human Primary C...
Methods and Approaches for Defining Mechanism Signatures from Human Primary C...Methods and Approaches for Defining Mechanism Signatures from Human Primary C...
Methods and Approaches for Defining Mechanism Signatures from Human Primary C...
BioMAP® Systems
 
Journal Combinatorial Chemistry 2006 v8 p820
Journal Combinatorial Chemistry 2006 v8 p820Journal Combinatorial Chemistry 2006 v8 p820
Journal Combinatorial Chemistry 2006 v8 p820
Peter Tidswell
 
Cadd and molecular modeling for M.Pharm
Cadd and molecular modeling for M.PharmCadd and molecular modeling for M.Pharm
Cadd and molecular modeling for M.Pharm
Shikha Popali
 
Drug design
Drug designDrug design
Drug design
Shikha Popali
 
In silico softwares
In silico softwaresIn silico softwares
In silico softwares
Sagar Savale
 
Medicinal Chemistry Complete Notes
Medicinal Chemistry Complete NotesMedicinal Chemistry Complete Notes
Medicinal Chemistry Complete Notes
Ghulam Murtaza Hamad
 
Qsar Studies on Gallic Acid Derivatives and Molecular Docking Studies of Bace...
Qsar Studies on Gallic Acid Derivatives and Molecular Docking Studies of Bace...Qsar Studies on Gallic Acid Derivatives and Molecular Docking Studies of Bace...
Qsar Studies on Gallic Acid Derivatives and Molecular Docking Studies of Bace...
bioejjournal
 
Qsar studies on gallic acid derivatives and molecular docking studies of bace...
Qsar studies on gallic acid derivatives and molecular docking studies of bace...Qsar studies on gallic acid derivatives and molecular docking studies of bace...
Qsar studies on gallic acid derivatives and molecular docking studies of bace...
bioejjournal
 

Similar to Introduction to OECD QSAR Toolbox (20)

qsar.pptx
qsar.pptxqsar.pptx
qsar.pptx
 
Raypur(NEW) QSAR.pptx
Raypur(NEW) QSAR.pptxRaypur(NEW) QSAR.pptx
Raypur(NEW) QSAR.pptx
 
Raypur(NEW) QSAR.pptx
Raypur(NEW) QSAR.pptxRaypur(NEW) QSAR.pptx
Raypur(NEW) QSAR.pptx
 
General Concepts in QSAR for Using the QSAR Application Toolbox Part 2
General Concepts in QSAR for Using the QSAR Application Toolbox Part 2General Concepts in QSAR for Using the QSAR Application Toolbox Part 2
General Concepts in QSAR for Using the QSAR Application Toolbox Part 2
 
Computer-aided prediction of xenobiotics toxicity
Computer-aided prediction of xenobiotics toxicityComputer-aided prediction of xenobiotics toxicity
Computer-aided prediction of xenobiotics toxicity
 
Exploiting enhanced non-testing approaches to meet the needs for sustainable ...
Exploiting enhanced non-testing approaches to meet the needs for sustainable ...Exploiting enhanced non-testing approaches to meet the needs for sustainable ...
Exploiting enhanced non-testing approaches to meet the needs for sustainable ...
 
QSPR For Pharmacokinetics
QSPR For PharmacokineticsQSPR For Pharmacokinetics
QSPR For Pharmacokinetics
 
Qsar ppt
Qsar pptQsar ppt
Qsar ppt
 
E0362430
E0362430E0362430
E0362430
 
cadd-191129134050 (1).pptx
cadd-191129134050 (1).pptxcadd-191129134050 (1).pptx
cadd-191129134050 (1).pptx
 
Drug development approaches
Drug development approaches Drug development approaches
Drug development approaches
 
CADD
CADDCADD
CADD
 
Methods and Approaches for Defining Mechanism Signatures from Human Primary C...
Methods and Approaches for Defining Mechanism Signatures from Human Primary C...Methods and Approaches for Defining Mechanism Signatures from Human Primary C...
Methods and Approaches for Defining Mechanism Signatures from Human Primary C...
 
Journal Combinatorial Chemistry 2006 v8 p820
Journal Combinatorial Chemistry 2006 v8 p820Journal Combinatorial Chemistry 2006 v8 p820
Journal Combinatorial Chemistry 2006 v8 p820
 
Cadd and molecular modeling for M.Pharm
Cadd and molecular modeling for M.PharmCadd and molecular modeling for M.Pharm
Cadd and molecular modeling for M.Pharm
 
Drug design
Drug designDrug design
Drug design
 
In silico softwares
In silico softwaresIn silico softwares
In silico softwares
 
Medicinal Chemistry Complete Notes
Medicinal Chemistry Complete NotesMedicinal Chemistry Complete Notes
Medicinal Chemistry Complete Notes
 
Qsar Studies on Gallic Acid Derivatives and Molecular Docking Studies of Bace...
Qsar Studies on Gallic Acid Derivatives and Molecular Docking Studies of Bace...Qsar Studies on Gallic Acid Derivatives and Molecular Docking Studies of Bace...
Qsar Studies on Gallic Acid Derivatives and Molecular Docking Studies of Bace...
 
Qsar studies on gallic acid derivatives and molecular docking studies of bace...
Qsar studies on gallic acid derivatives and molecular docking studies of bace...Qsar studies on gallic acid derivatives and molecular docking studies of bace...
Qsar studies on gallic acid derivatives and molecular docking studies of bace...
 

Recently uploaded

Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...
Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...
Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...
UiPathCommunity
 
Slack (or Teams) Automation for Bonterra Impact Management (fka Social Soluti...
Slack (or Teams) Automation for Bonterra Impact Management (fka Social Soluti...Slack (or Teams) Automation for Bonterra Impact Management (fka Social Soluti...
Slack (or Teams) Automation for Bonterra Impact Management (fka Social Soluti...
Jeffrey Haguewood
 
FIDO Alliance Osaka Seminar: Passkeys at Amazon.pdf
FIDO Alliance Osaka Seminar: Passkeys at Amazon.pdfFIDO Alliance Osaka Seminar: Passkeys at Amazon.pdf
FIDO Alliance Osaka Seminar: Passkeys at Amazon.pdf
FIDO Alliance
 
How world-class product teams are winning in the AI era by CEO and Founder, P...
How world-class product teams are winning in the AI era by CEO and Founder, P...How world-class product teams are winning in the AI era by CEO and Founder, P...
How world-class product teams are winning in the AI era by CEO and Founder, P...
Product School
 
JMeter webinar - integration with InfluxDB and Grafana
JMeter webinar - integration with InfluxDB and GrafanaJMeter webinar - integration with InfluxDB and Grafana
JMeter webinar - integration with InfluxDB and Grafana
RTTS
 
PCI PIN Basics Webinar from the Controlcase Team
PCI PIN Basics Webinar from the Controlcase TeamPCI PIN Basics Webinar from the Controlcase Team
PCI PIN Basics Webinar from the Controlcase Team
ControlCase
 
Transcript: Selling digital books in 2024: Insights from industry leaders - T...
Transcript: Selling digital books in 2024: Insights from industry leaders - T...Transcript: Selling digital books in 2024: Insights from industry leaders - T...
Transcript: Selling digital books in 2024: Insights from industry leaders - T...
BookNet Canada
 
Mission to Decommission: Importance of Decommissioning Products to Increase E...
Mission to Decommission: Importance of Decommissioning Products to Increase E...Mission to Decommission: Importance of Decommissioning Products to Increase E...
Mission to Decommission: Importance of Decommissioning Products to Increase E...
Product School
 
Knowledge engineering: from people to machines and back
Knowledge engineering: from people to machines and backKnowledge engineering: from people to machines and back
Knowledge engineering: from people to machines and back
Elena Simperl
 
The Art of the Pitch: WordPress Relationships and Sales
The Art of the Pitch: WordPress Relationships and SalesThe Art of the Pitch: WordPress Relationships and Sales
The Art of the Pitch: WordPress Relationships and Sales
Laura Byrne
 
Designing Great Products: The Power of Design and Leadership by Chief Designe...
Designing Great Products: The Power of Design and Leadership by Chief Designe...Designing Great Products: The Power of Design and Leadership by Chief Designe...
Designing Great Products: The Power of Design and Leadership by Chief Designe...
Product School
 
De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...
De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...
De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...
Product School
 
Bits & Pixels using AI for Good.........
Bits & Pixels using AI for Good.........Bits & Pixels using AI for Good.........
Bits & Pixels using AI for Good.........
Alison B. Lowndes
 
Epistemic Interaction - tuning interfaces to provide information for AI support
Epistemic Interaction - tuning interfaces to provide information for AI supportEpistemic Interaction - tuning interfaces to provide information for AI support
Epistemic Interaction - tuning interfaces to provide information for AI support
Alan Dix
 
Securing your Kubernetes cluster_ a step-by-step guide to success !
Securing your Kubernetes cluster_ a step-by-step guide to success !Securing your Kubernetes cluster_ a step-by-step guide to success !
Securing your Kubernetes cluster_ a step-by-step guide to success !
KatiaHIMEUR1
 
FIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdf
FIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdfFIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdf
FIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdf
FIDO Alliance
 
State of ICS and IoT Cyber Threat Landscape Report 2024 preview
State of ICS and IoT Cyber Threat Landscape Report 2024 previewState of ICS and IoT Cyber Threat Landscape Report 2024 preview
State of ICS and IoT Cyber Threat Landscape Report 2024 preview
Prayukth K V
 
Monitoring Java Application Security with JDK Tools and JFR Events
Monitoring Java Application Security with JDK Tools and JFR EventsMonitoring Java Application Security with JDK Tools and JFR Events
Monitoring Java Application Security with JDK Tools and JFR Events
Ana-Maria Mihalceanu
 
GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...
GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...
GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...
Sri Ambati
 
FIDO Alliance Osaka Seminar: Overview.pdf
FIDO Alliance Osaka Seminar: Overview.pdfFIDO Alliance Osaka Seminar: Overview.pdf
FIDO Alliance Osaka Seminar: Overview.pdf
FIDO Alliance
 

Recently uploaded (20)

Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...
Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...
Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...
 
Slack (or Teams) Automation for Bonterra Impact Management (fka Social Soluti...
Slack (or Teams) Automation for Bonterra Impact Management (fka Social Soluti...Slack (or Teams) Automation for Bonterra Impact Management (fka Social Soluti...
Slack (or Teams) Automation for Bonterra Impact Management (fka Social Soluti...
 
FIDO Alliance Osaka Seminar: Passkeys at Amazon.pdf
FIDO Alliance Osaka Seminar: Passkeys at Amazon.pdfFIDO Alliance Osaka Seminar: Passkeys at Amazon.pdf
FIDO Alliance Osaka Seminar: Passkeys at Amazon.pdf
 
How world-class product teams are winning in the AI era by CEO and Founder, P...
How world-class product teams are winning in the AI era by CEO and Founder, P...How world-class product teams are winning in the AI era by CEO and Founder, P...
How world-class product teams are winning in the AI era by CEO and Founder, P...
 
JMeter webinar - integration with InfluxDB and Grafana
JMeter webinar - integration with InfluxDB and GrafanaJMeter webinar - integration with InfluxDB and Grafana
JMeter webinar - integration with InfluxDB and Grafana
 
PCI PIN Basics Webinar from the Controlcase Team
PCI PIN Basics Webinar from the Controlcase TeamPCI PIN Basics Webinar from the Controlcase Team
PCI PIN Basics Webinar from the Controlcase Team
 
Transcript: Selling digital books in 2024: Insights from industry leaders - T...
Transcript: Selling digital books in 2024: Insights from industry leaders - T...Transcript: Selling digital books in 2024: Insights from industry leaders - T...
Transcript: Selling digital books in 2024: Insights from industry leaders - T...
 
Mission to Decommission: Importance of Decommissioning Products to Increase E...
Mission to Decommission: Importance of Decommissioning Products to Increase E...Mission to Decommission: Importance of Decommissioning Products to Increase E...
Mission to Decommission: Importance of Decommissioning Products to Increase E...
 
Knowledge engineering: from people to machines and back
Knowledge engineering: from people to machines and backKnowledge engineering: from people to machines and back
Knowledge engineering: from people to machines and back
 
The Art of the Pitch: WordPress Relationships and Sales
The Art of the Pitch: WordPress Relationships and SalesThe Art of the Pitch: WordPress Relationships and Sales
The Art of the Pitch: WordPress Relationships and Sales
 
Designing Great Products: The Power of Design and Leadership by Chief Designe...
Designing Great Products: The Power of Design and Leadership by Chief Designe...Designing Great Products: The Power of Design and Leadership by Chief Designe...
Designing Great Products: The Power of Design and Leadership by Chief Designe...
 
De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...
De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...
De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...
 
Bits & Pixels using AI for Good.........
Bits & Pixels using AI for Good.........Bits & Pixels using AI for Good.........
Bits & Pixels using AI for Good.........
 
Epistemic Interaction - tuning interfaces to provide information for AI support
Epistemic Interaction - tuning interfaces to provide information for AI supportEpistemic Interaction - tuning interfaces to provide information for AI support
Epistemic Interaction - tuning interfaces to provide information for AI support
 
Securing your Kubernetes cluster_ a step-by-step guide to success !
Securing your Kubernetes cluster_ a step-by-step guide to success !Securing your Kubernetes cluster_ a step-by-step guide to success !
Securing your Kubernetes cluster_ a step-by-step guide to success !
 
FIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdf
FIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdfFIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdf
FIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdf
 
State of ICS and IoT Cyber Threat Landscape Report 2024 preview
State of ICS and IoT Cyber Threat Landscape Report 2024 previewState of ICS and IoT Cyber Threat Landscape Report 2024 preview
State of ICS and IoT Cyber Threat Landscape Report 2024 preview
 
Monitoring Java Application Security with JDK Tools and JFR Events
Monitoring Java Application Security with JDK Tools and JFR EventsMonitoring Java Application Security with JDK Tools and JFR Events
Monitoring Java Application Security with JDK Tools and JFR Events
 
GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...
GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...
GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...
 
FIDO Alliance Osaka Seminar: Overview.pdf
FIDO Alliance Osaka Seminar: Overview.pdfFIDO Alliance Osaka Seminar: Overview.pdf
FIDO Alliance Osaka Seminar: Overview.pdf
 

Introduction to OECD QSAR Toolbox

  • 1.
  • 2. Risk assessments are based on test data, and QSAR is not needed if you have lot’s of data
  • 3.
  • 4. The world inventory of produced chemicals exceeds 160,000 chemicals
  • 5.
  • 6. Also, priority setting for 130,000 chemicals will require faster testing or better models
  • 7.
  • 8. Like most systems, the behavior of a chemical is derived from its structure
  • 9.
  • 10. QSAR is the acronym for Quantitative Structure-Activity Relationship
  • 11.
  • 12. There are more than 15,000 published QSARs for biological activity endpoints
  • 13.
  • 14. Only chemicals causing common toxicity mechanisms lead to a reliable QSAR
  • 15.
  • 16. Each QSAR predicts a specific endpoint and only for chemicals with the same mechanism
  • 17.
  • 18.
  • 19. Data restricted to alkyl ethers to increase likelihood of a similar toxicity mechanism
  • 20. Estimate or measure vapor pressure as molecular descriptor (selected from theory or by trial-n-error)
  • 21. Correlate LC50 with VP to get: log LC50 = 0.57 x log VP + 2.08
  • 22.
  • 23.
  • 24. Notice the intercept is about 0.5 log units greater for 30 min mouse vs 4 hr rat LC50
  • 25.
  • 26. This QSAR implies vapor pressure is important to the lethality mechanism for these chemicals
  • 27. Chemicals with other mechanisms (i.e. acrolein, phosgene) will appear as statistical outliers
  • 28.
  • 29.
  • 30. Entire categories of chemicals can be assessed when only a few are tested
  • 31.
  • 32. Annex IX of REACH Substances whose physicochemical, toxicological and ecotoxicological properties are likely to besimilar or follow a regular patternas a result of structural similarity may be considered as a group, or “category” of substances. Application of the group concept requires that physicochemical properties, human health effects and environmental effects or environmental fate may bepredicted from data for a reference substancewithin the group by interpolation to other substances in the group (read-across approach). Thisavoids the need to test every substance for every endpoint.
  • 33.
  • 34. These structural similarities may create a predictable pattern in any or all of the following parameters: physicochemical properties, environmental fate and environmental effects, and human health effectsOECD Manual for Investigation of High Production Volume (HPV) Chemicals.
  • 35. Forming Chemical Categories Chemical categories have boundary conditions which vary with endpoints Without detailed understanding of metabolism or mechanisms, grouping similarity of behavior is difficult to define. Ironically, examining data trends with different category boundaries is a flexible way to define categories
  • 36. Canonical Ordering Chemical Amyl amine Amyl chloride Dibromobenzene Ethyl bromide n-Heptanol Methacrolein Methyl-p-anisylketone n-Octane n-Nonane Boiling Point °C 103-4 98-9 219-2 38.4 192 68 267-9 126 151
  • 37. Canonical Ordering Chemical Ethyl bromide Methacrolein Amyl chloride Amyl amine n-Octane n-Nonane n-Heptanol Dibromobenzene Methyl-p-anisylketone Boiling Point °C 38.4 68 98-9 103-4 126 151 192 219-2 267-9
  • 38. Modeling Chemical Potency 10+2 10 0 10_2 1/LC50 (Moles/L) It is not uncommon to find endpoint values spanning 6-10 orders for a single toxicity mechanism 10_4 10_6 10-8 1 2 3 4 5 N < 10,000 ….... TOXICITY “MECHANISMS”
  • 39. Modeling Chemical Potency 10+2 10 0 10_2 1/LC50 (Chemical Activity) 10_4 10_6 10-8 0 2 4 6 8 LOG K o/w
  • 40. QSAR Methods QSAR fills data gaps by first grouping chemicals and then using existing data within a group to estimate missing values When the chemical group is identified by a common mechanism, QSAR models can accurately describe the trends
  • 41. Why Do We Need the QSAR Toolbox Defining category boundaries requires the calculation of complex attributes of chemicals to determine which best explains available data In many cases, metabolic simulators are needed to provide metabolic maps and active metabolites To do trend analysis, hundreds of available data must be compiled and flexibly analyzed for trends
  • 42. Which Metabolite should we use in modeling interactions? Simulated 2-Acetylaminofluorene Metabolism
  • 43. Adverse Outcome Pathway For A Well-Defined Endpoint Molecular Initiating Event Speciation, Metabolism Reactivity Etc. In Vitro and System Effects In Vivo Adverse Outcomes Parent Chemical Up-Stream Down-Stream CHEMISTRYBIOLOGY Structure-Activity Levels of Organization
  • 44. MolecularInitiating Event Macro -Molecular Interactions Toxicant Chemical Reactivity Profiles Receptor, DNA, Protein Interactions Biological Responses Mechanistic Profiling The Adverse Outcome Pathway
  • 45. MolecularInitiating Event Biological Responses Macro -Molecular Interactions Toxicant Cellular Gene Activation Protein Production Signal Alteration Chemical Reactivity Profiles Receptor, DNA, Protein Interactions NRC Toxicological Pathway The Adverse Outcome Pathway
  • 46. MolecularInitiating Event Biological Responses Macro -Molecular Interactions Tissue/ Organ Toxicant Cellular Gene Activation Protein Production Signal Alteration Receptor, DNA, Protein Interactions Altered Function Altered Development Chemical Reactivity Profiles Mechanistic Profiling In Vitro & HTP Screening The Adverse Outcome Pathway
  • 47. MolecularInitiating Event Biological Responses Macro -Molecular Interactions Toxicant Cellular Organism Organ Population Lethality Sensitization Birth Defect Reproductive Impairment Cancer Gene Activation Protein Production Signal Alteration Altered Function Altered Development Chemical Reactivity Profiles Receptor, DNA, Protein Interactions Structure Extinction Mechanistic Profiling In Vivo Testing In Vitro & HTP Screening The Adverse Outcome Pathway
  • 48. Major Pathways for Reactive Toxicity from Moderate Electrophiles Interaction Mechanisms Molecular Initiating Events In vivo Endpoints Exposed Surface Irritation Michael Addition Schiff base Formation SN2 Acylation Atom Centered Irreversible (Covalent) Binding Necrosis Which Tissues? Pr-S Adducts GSH Oxidation GSH Depletion NH2 Adducts RN Adducts DNA Adducts Oxidative Stress Systemic Responses Skin Liver Lung Systemic Immune Responses Dose-Dependent Effects
  • 49. Organization for Economic Co-operation and Development QSARApplication Toolbox -filling data gaps using available information- Training Workshop Barcelona
  • 50.
  • 51.
  • 52. Organized actions of EU and OECD – coming with REACH
  • 53. The role of the “revolutionary” notions – category, analogues
  • 54. OECD and EU Guidance documents on ‘Category’, ‘QSAR’
  • 55.
  • 56. Facilitate selection of chemical analogues and categories
  • 58. Assist in the estimation of missing values for chemicals-ENV/JM(2006)47
  • 59. Typical queries included in the (Q)SAR Application Toolbox Is the chemical included in regulatory inventories or existing chemical categories? Has the chemical already been assessed by other agencies/organisations? Would you like to search for available data on assessment endpoints for each chemical?
  • 60. Typical Queries included in the (Q)SAR Application Toolbox Explore a chemical list for possible analogues using predefined, mechanistic, empiric and custom built categorization schemes? Group chemicals based on common chemical/toxic mechanism and/or metabolism? Design a data matrix of a chemical category?
  • 61. QSAR Toolbox Workflow The workflow in the first version of the QSAR Toolbox is to facilitate hazard assessors in the creating of chemical categories which enable data to be extrapolated from tested chemicals to untested members of categories
  • 62. Logical sequence of components usage Chemical input Profiling Category Definition Filling data gap Report Endpoints
  • 63.
  • 64. CAS#
  • 67.
  • 69.
  • 74.
  • 76. US EPA categorization
  • 80.
  • 81. Toolbox databases
  • 82. Publicly available
  • 83. Proprietary databases
  • 84. Toolbox Links to External Databases (DSSTOX)
  • 85. Selecting type of extracting data:
  • 86. Measured Data
  • 87. Estimated Data
  • 88.
  • 92.
  • 97.
  • 99.
  • 100. IUCLID 5 Harmonized Templates
  • 102. History of the Toolbox Application

Editor's Notes

  1. The simplest exercise in QSAR is canonical ordering which starts with choosing a group of chemicals, and a selected property or biological activity for each. In this slide, nine chemicals are listed with their boiling points. If we think we understand how chemical structure relates to boiling point, we would expect that those molecular descriptors would place the chemicals in the same order as would the boiling point.
  2. In this slide, the chemicals are sorted by increasing boiling point. Can we identify molecular descriptors that create the same order. If not, we do understand the inter and intramolecular forces that control boiling point. If QSAR can order them properly, the task is then to find chemicals that fit between these values an test the QSAR model. Through numerous iterations , theoretical explanations can be evaluated for relevance and the important molecular descriptors are discovered. This came approach can be used for toxicity data provided a similar toxicity mechanism can be expected for the chemicals.
  3. In this example, I am illustrating that there are many toxicity mechanisms, and if all the chemicals having the same mechanism are compiled, it would not be unusual for the potency of those chemicals to range over 8-10 orders of magnitude. Even if the range were much less, the first challenge for QSAR would be to identify a molecular descriptor that places the chemicals in the same order as the potency measures (LC50). To illustrate, I am using aquatic lethality with fish just to move away from the rodent inhalation example, but keep in mind that a fish test is just an inhalation test with aquatic organisms.
  4. For many mechanisms, uptake of the chemicals is controlled by passive transport and one would expect the octanol/water partition coefficient to covary with passive transport. When the entire range of potency values are plotted vesus Log Ko/w, the chemicals remain in the same order and quantitative relationship between LC50 and Ko/w can be derived exactly like that for the rodent inhalation data.